FDA Clearance Tracker · P950014-S026
UROLOGIX PROSTATRON SYSTEM
Last checked: Nov 20, 2026Latest source record: Jul 16, 2008 (this decision)Source: openFDAMethods & limitations
Decided
Jul 16, 2008
Approved
Time to decision
124 days
Received Mar 14, 2008. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track
Device class
Class III
The decision
- FDA number
- P950014-S026
- Device name
- UROLOGIX PROSTATRON SYSTEM
- Applicant
- Urologix, Inc.
- Applicant location
- Plymouth, MN
- Received
- Mar 14, 2008
- Decided
- Jul 16, 2008
- Decision
- Approved
- Supplement type
- Normal 180 Day Track
- Reason for supplement
- Change Design/Components/Specifications/Material
- Original approval
- P950014
Device type
- Device class
- Class III
- Specialty
- GI, Urology & NephrologyUrology
FDA's approval statement
As written in FDA's record.
APPROVAL FOR DESIGN MODIFICATIONS WHICH INCLUDE A NEW CATHETER TIP MATERIAL, RED MARK ADHESIVE, BONDING ADHESIVES, INJECTION MOLD FOR MANUFACTURING THE CATHETER TIP, AND A NEW STERILE BALLOON INFLATION STOPCOCK. THE PRODUCTION OF THE PROSTAPROBE TYPE II, SILICONE, BLUE TREATMENT CATHETER (PART NUMBER 410053-004) WILL BE MANUFACTURED AT MEDTECH COSTA RICA, SA, COSTA RICA, CENTRAL AMERICA.
Source documents
Other decisions for Urologix, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
K142248 · Decided Feb 20, 2015 · 190 days after receipt
Device type: Electrosurgical, Cutting & Coagulation & Accessories (GEI) · General & Plastic Surgery
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.